Enterprise Value
56.81M
Cash
95.61M
Avg Qtr Burn
-17.49M
Short % of Float
2.97%
Insider Ownership
6.91%
Institutional Own.
64.28%
Qtr Updated
03/31/23
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
TSC-100 & TSC-101 Details Cancer, Hematologic malignancies | Phase 2 Interim update |